{
    "address1": "9540 Towne Centre Drive",
    "address2": "Suite 100",
    "city": "San Diego",
    "state": "CA",
    "zip": "92121",
    "country": "United States",
    "phone": "858 888 7600",
    "website": "https://bionano.com",
    "industry": "Medical Instruments & Supplies",
    "sector": "Healthcare",
    "longBusinessSummary": "Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.",
    "fullTimeEmployees": 405,
    "companyOfficers": [
        {
            "maxAge": 1,
            "name": "Dr. Robert Erik Holmlin M.B.A., Ph.D.",
            "age": 54,
            "title": "Pres, CEO, Sec. & Director",
            "yearBorn": 1968,
            "fiscalYear": 2022,
            "totalPay": 834572,
            "exercisedValue": 0,
            "unexercisedValue": 101674
        },
        {
            "maxAge": 1,
            "name": "Mr. Mark  Oldakowski",
            "age": 48,
            "title": "Chief Operating Officer",
            "yearBorn": 1974,
            "fiscalYear": 2022,
            "totalPay": 603824,
            "exercisedValue": 0,
            "unexercisedValue": 55875
        },
        {
            "maxAge": 1,
            "name": "Dr. Alka  Chaubey FACMG, Ph.D.",
            "age": 49,
            "title": "Chief Medical Officer",
            "yearBorn": 1973,
            "fiscalYear": 2022,
            "totalPay": 558829,
            "exercisedValue": 0,
            "unexercisedValue": 167100
        },
        {
            "maxAge": 1,
            "name": "Mr. Christopher P. Stewart",
            "age": 53,
            "title": "Chief Financial Officer",
            "yearBorn": 1969,
            "fiscalYear": 2020,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Mr. Mark  Adamchak CPA",
            "title": "VP of Accounting & Controller",
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Mr. Jonathan  Dixon J.D.",
            "age": 47,
            "title": "Gen. Counsel",
            "yearBorn": 1975,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Mr. Stanislas  Marin M.B.A., M.S.",
            "title": "VP of Global Sales",
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Ms. Donna  Polizio",
            "title": "Global Head of Market Access",
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Mr. Cory  Kreeck",
            "title": "Global Head of People Operations",
            "exercisedValue": 0,
            "unexercisedValue": 0
        }
    ],
    "auditRisk": 9,
    "boardRisk": 7,
    "compensationRisk": 10,
    "shareHolderRightsRisk": 8,
    "overallRisk": 10,
    "governanceEpochDate": 1693526400,
    "compensationAsOfEpochDate": 1672444800,
    "maxAge": 86400,
    "priceHint": 4,
    "previousClose": 3.365,
    "open": 3.36,
    "dayLow": 3.24,
    "dayHigh": 3.4,
    "regularMarketPreviousClose": 3.365,
    "regularMarketOpen": 3.36,
    "regularMarketDayLow": 3.24,
    "regularMarketDayHigh": 3.4,
    "payoutRatio": 0.0,
    "beta": 2.17919,
    "forwardPE": -1.043077,
    "volume": 457118,
    "regularMarketVolume": 457118,
    "averageVolume": 1122995,
    "averageVolume10days": 1010190,
    "averageDailyVolume10Day": 1010190,
    "bid": 0.0,
    "ask": 0.0,
    "bidSize": 1300,
    "askSize": 800,
    "marketCap": 119831080,
    "fiftyTwoWeekLow": 2.95,
    "fiftyTwoWeekHigh": 30.1,
    "priceToSalesTrailing12Months": 3.802592,
    "fiftyDayAverage": 4.8172,
    "twoHundredDayAverage": 10.7318,
    "trailingAnnualDividendRate": 0.0,
    "trailingAnnualDividendYield": 0.0,
    "currency": "USD",
    "enterpriseValue": 53432212,
    "profitMargins": 0.0,
    "floatShares": 35165689,
    "sharesOutstanding": 35348400,
    "sharesShort": 4137809,
    "sharesShortPriorMonth": 4391265,
    "sharesShortPreviousMonthDate": 1689292800,
    "dateShortInterest": 1692057600,
    "sharesPercentSharesOut": 0.1171,
    "shortRatio": 3.45,
    "shortPercentOfFloat": 0.1176,
    "bookValue": 6.461,
    "priceToBook": 0.5246866,
    "lastFiscalYearEnd": 1672444800,
    "nextFiscalYearEnd": 1703980800,
    "mostRecentQuarter": 1688083200,
    "netIncomeToCommon": -146522000,
    "trailingEps": -6.59,
    "forwardEps": -3.25,
    "enterpriseToRevenue": 1.696,
    "enterpriseToEbitda": -0.402,
    "exchange": "NCM",
    "quoteType": "EQUITY",
    "symbol": "BNGO",
    "underlyingSymbol": "BNGO",
    "shortName": "Bionano Genomics, Inc.",
    "longName": "Bionano Genomics, Inc.",
    "firstTradeDateEpochUtc": 1534858200,
    "timeZoneFullName": "America/New_York",
    "timeZoneShortName": "EDT",
    "gmtOffSetMilliseconds": -14400000,
    "currentPrice": 3.39,
    "targetHighPrice": 32.0,
    "targetLowPrice": 9.0,
    "targetMeanPrice": 20.2,
    "targetMedianPrice": 20.0,
    "recommendationMean": 1.4,
    "recommendationKey": "strong_buy",
    "numberOfAnalystOpinions": 5,
    "totalCash": 77062000,
    "totalCashPerShare": 2.18,
    "ebitda": -133023000,
    "totalDebt": 10663000,
    "quickRatio": 2.54,
    "currentRatio": 3.659,
    "totalRevenue": 31513000,
    "debtToEquity": 4.965,
    "revenuePerShare": 1.047,
    "returnOnAssets": -0.30493,
    "returnOnEquity": -0.58669,
    "grossProfits": 5945000,
    "freeCashflow": -73333624,
    "operatingCashflow": -133099000,
    "revenueGrowth": 0.299,
    "grossMargins": 0.25355,
    "ebitdaMargins": 0.0,
    "operatingMargins": -4.58988,
    "financialCurrency": "USD",
    "trailingPegRatio": null,
    "parent_etfs": [
        "EDOC",
        "GNOM"
    ]
}